0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Cardiovascular medicine

Buy Now

The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Paperback, Softcover reprint of the original 1st ed. 1982) Loot Price: R1,442
Discovery Miles 14 420
The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Paperback, Softcover reprint of the original 1st ed. 1982): J....

The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Paperback, Softcover reprint of the original 1st ed. 1982)

J. Morganroth, E.Neil Moore

Series: Developments in Cardiovascular Medicine, 18

 (sign in to rate)
Loot Price R1,442 Discovery Miles 14 420 | Repayment Terms: R135 pm x 12*

Bookmark and Share

Expected to ship within 18 - 22 working days

With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States.

General

Imprint: Springer
Country of origin: Netherlands
Series: Developments in Cardiovascular Medicine, 18
Release date: November 2011
First published: 1982
Editors: J. Morganroth • E.Neil Moore
Dimensions: 235 x 155 x 21mm (L x W x T)
Format: Paperback
Pages: 419
Edition: Softcover reprint of the original 1st ed. 1982
ISBN-13: 978-9400975637
Categories: Books > Medicine > Clinical & internal medicine > Cardiovascular medicine
Promotions
LSN: 9400975635
Barcode: 9789400975637

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Herbal Bioactive-Based Drug Delivery…
Inderbir Singh Bakshi, Rajni Bala, … Paperback R3,967 Discovery Miles 39 670
Membranes in Pulmonary Vascular Disease…
Patrick Belvitch, Steven Dudek Hardcover R4,414 Discovery Miles 44 140
Encyclopedia of Cardiovascular Research…
Douglas B. Sawyer, Ramachandran S. Vasan Hardcover R43,507 Discovery Miles 435 070
Have You Planned Your Heart Attack…
Warrick Bishop Hardcover R1,507 Discovery Miles 15 070
Plaque Imaging, An Issue of Neuroimaging…
J Kevin DeMarco Hardcover R1,702 Discovery Miles 17 020
Coronary Artery Disease, An Issue of…
David Shavelle Hardcover R1,693 Discovery Miles 16 930
Stroke Rehabilitation, An Issue of…
John Chae Hardcover R1,684 Discovery Miles 16 840
Heart Failure, An Issue of Critical…
Jennifer Kitchens Hardcover R1,687 Discovery Miles 16 870
Team-Based Care for Heart Failure, An…
Gregg C. Fonarow Hardcover R1,697 Discovery Miles 16 970
Lipidology, An Issue of Cardiology…
Edward A. Gill Hardcover R1,696 Discovery Miles 16 960
Updates in Cardiac MRI, An Issue of…
Karen Ordovas Hardcover R1,670 Discovery Miles 16 700
Vasculitis in Rheumatic Diseases, An…
Daniel A. Albert Hardcover R1,664 Discovery Miles 16 640

See more

Partners